Skip to content

VaxGen trials likely to go to full term

First results from Oxford-Nairobi vaccine trials

Pharma companies agree further price cuts as generics challenge

Drug resistant new infections could reach one in seven by 2005

New British treatment guidelines finalised

Harmless hepatitis G slows HIV disease

Private sector plans treatment access for workers

AIDS Vaccine 2001 opens in Philadelphia

Antiretroviral therapy in Africa: what is needed?